18 0.14 *In generalized linear models, all variables listed, race and clinic site were included simultaneously. For AIx, model was adjusted for height at the time of the measure and waist AUC, other outcomes use NHANES waist to height ratio area under the curve (AUC). AIx = augmentation index; PWVcf = pulse wave velocity, carotidfemoral; PWVft = pulse wave velocity, femoral-foot, PWVcr = pulse wave velocity, carotid-radial.
Reduced model excludes the variables that in the tables have a p-value labeled as NS. †HbA1c = glycated hemoblobin, T1D = type 1 diabetes, MAP = mean arterial pressure, BP med = blood pressure lowering medication, CAN = cardiac autonomic neuropathy, lipid med = lipid lowering medication. Variables included in the minimally adjusted models are the variable of interest, age at diagnosis, duration of diabetes, sex, race, and clinical site. When testing interactions, the main effects were also included in the model (not presented). *The full model includes variables with results, age at diagnosis, duration of diabetes, sex, race, use of BP or lipid medication, smoking, sedentary behavior, and clinic site. **This reduced model includes variables used in the full model that were significant and main effects of interactions.
Variables included in the model that are not in the table include age at diagnosis, duration of diabetes, sex, race, and clinic site. †HbA1c = glycated hemoglobin, MAP = mean arterial pressure, BP med = blood pressure lowering medication, CAN = cardiac autonomic neuropathy, lipid med = lipid lowering medication. AIx = augmentation index; PWVcf = pulse wave velocity, carotid-femoral; PWVft = pulse wave velocity, femoral-foot, PWVcr = pulse wave velocity, carotid-radial.
